|
Main Sponsor |
The Co-sponsors Baker & McKenzie |
|
Bank Vontobel Vontobel Group is a traditional Swiss private banking group offering superior financial services to clients around the world. It is focused on four business areas: private banking, investment banking, asset management and investment funds. Vontobel Group is one of the leading Swiss portfolio managers for private and institutional clients with more than CHF 76,7 billion under management as of the end of December 2000. It has representative offices in Zurich, Geneva, Cologne, Salzburg, Vienna and New York as well as in other locations. In the investment banking business, Vontobel concentrates on brokerage, trading, and corporate finance. The Corporate Finance Division at Bank Vontobel AG has acted as lead underwriter in the initial public and secondary offerings of numerous high-growth companies – primarily in the field of life sciences and advanced technology. Vontobel Holding bearer shares have been listed on
the Swiss Exchange since 1986. A key element of the Group’s
identity is its independence. The Vontobel family, the Vontobel-Foundation
and management own a majority of the share capital. This ownership
structure makes Vontobel one of the few truly independent banking
groups in Switzerland. |
 |
|
Baker & McKenzie Baker & McKenzie is a leading global law firm with 62 offices in 35 countries. With a multinational network of more than 4,100 legal professionals and a presence in virtually every important financial and commercial centre worldwide, we offer our clients a global service unrivalled by any other law firm. Since its inception in 1949, Baker & McKenzie has been committed to building a seamless global network of offices staffed by locally qualified lawyers who are indigenous to the business communities in which they and their clients operate. Our lawyers work in national, regional and global practice groups in their areas of expertise to help our clients achieve their objectives. We are active members of venture capital professional
bodies around the world, including European venture capital associations.
We are also involved in a number of industry partnerships and sponsorships
and are regular judges of prestigious business plan competitions. |
 |
|
DVC Deutsche Venture Capital DVC Deutsche Venture Capital is an independent Venture capital firm focussing on investment in early stages in companies with a high potential for success in global markets. We concentrate our investments in early stages of technology companies in high growth industries like information- and communications technologies, life science and microsystems and nanotechnolgy. We want to contribute our skills, experience and network to the sucesss of our portfolio companies. We are privileged to have valuable global partnership with Deutsche Bank AG. Deutsche Venture is your partner for transantlantic situations. We offer our help to enter the US and European market and we support you in developing the long range plan for your global expansion. Each sector has a team of focussed investment managers
with a combination of technical, operational and financial skills.
Due to our business and venture capital experience and our international
contacts we support our portfolio companies and their management
to have success in the international market . |
|
|
Katan Associates After 35 years of successful business career, Stan
Yakatan is offering his services on an advisory basis to a selective
group of clients. He assists in consulting and developing a strategic
plan, incorporate partnering as well as reorganizations, acquisitions,
joint ventures. Mr. Yakatan also assists organizations in seed capital,
venture capital, private placements and in developing exits leading
to public offerings both from an IPO perspective as well as from
a reverse takeover perspective. Mr. Yakatan has expertise in agricultural
products, biotechnology products, biopharmaceutical products, genome
projects, veterinary, cosmetics, instrumentation and reagents. His
organization assists in developing a business plan focused on the
current growth of a company and in arranging financing, negotiating
mergers and acquisitions as well as private consulting. |
 |
|
Kirchhoff Consult AG Kirchhoff Consult consists of a team of financial analysts,
IR experts,issuing consultants, business journalists and communication
designers. Our aim is to create a lively, convincing and sustained
dialog between businesses and investors at each stage of a company's
development. We advise start-ups during the entire capital procurement
process. We organize and design corporate communication both in
terms of content and visual aspects. All our staff members consider
themselves to be dedicated consultants and partners of their clients
at any particular time. We have both long-term mandates with significant
corporations listed on the DAX and innovative, successful start-up
companies. |
 |
|
Novartis Venture Fund The Novartis Venture Fund expresses our conviction
that economic growth and the creation of new jobs can be achieved
in the long run only if new entrepreneurial initiatives develop
and promising ideas become business reality. With a venture capital
of 100 million Swiss francs, the Novartis Venture Fund supports
new business projects that show exemplary entrepreneurial and innovative
spirit in future-oriented areas, especially in the fields of Life
Sciences and new technologies. |
 |
|
SWX Swiss Exchange Financing Growth on the SWX New Market – The high growth segment on the SWX Swiss Exchange The SWX Swiss Exchange is one of the world’s leading and most technologically advanced securities exchanges. In 1996, floor-based trading in Switzerland was supplanted by electronic trading. This fully automated trading, clearing and settlement system remains unique in the world. At the click of a mouse, an order is executed, cleared, paid for and confirmed. The SWX Swiss Exchange offers its customers first-rate securities exchange services and a broad range of investment products. The SWX
New Market provides innovative, international growth companies
– primarily from the life science, IT as well as the micro-
and nanotechnology industries – with access to the Swiss capital
market. A public offering in this segment affords issuing companies
a high degree of global visibility among investors, especially those
with a heightened interest in these sectors. An IPO in Switzerland
represents an attractive means of obtaining equity financing. |
|